{"ORPHApacket":[{"ORPHApacketID":"86904","date":"2019-12-05 19:09:06","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"86904","Name":[{"lang":"en","label":"Methotrexate-associated lymphoproliferative disorders"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_86904","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Immunodeficiency-associated lymphoproliferative disease"}],"ORPHA":"98290","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_98290"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Methotrexate-associated lymphoproliferative disorders are rare immunodeficiency-associated lymphoproliferative diseases characterized by lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients."}],"SynonymList":[{"count":"2","Synonym":[{"lang":"en","label":"MTX-LPD"},{"lang":"en","label":"MTX-associated lymphoproliferative disorders"}]}]}]}